Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2021-07-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
《董事会议事规则》（2021年7月修订稿）
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Board Meeting Rules" or "Rules of Procedure for the Board of Directors". It details the structure, responsibilities, powers, and procedures of the company's board of directors, including meeting protocols, voting rights, and the role of independent directors. There is no financial data, audit information, or report content. It is a governance document outlining internal rules and governance practices of the company. Therefore, it fits the category of Governance Information (CGR). The document length is sufficient and it is not an announcement or a brief notice, but a full governance rules document.
2021-07-28 Chinese
独立董事关于董事会换届选举的独立意见
Board/Management Information Classification · 100% confidence The document is an independent opinion from independent directors regarding the election of the company's board members, specifically about the nomination and qualifications of candidates for the board. It references compliance with laws and company regulations and provides approval for the nomination of certain individuals to the board. This is clearly related to board or management information, specifically about changes or elections in the board of directors. The document is not a full report, financial statement, or announcement of voting results, but a formal opinion on board member nominations. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short but contains substantive content about board changes, not just an announcement or notice.
2021-07-28 Chinese
《公司章程》（2021年7月修订稿）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 华邦生命健康股份有限公司. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, share transfer, shareholder meetings, voting procedures, and other governance matters. It is a comprehensive governance document that outlines the internal rules and regulations of the company rather than a financial report, announcement, or meeting minutes. There is no indication that this is an annual report, earnings release, proxy statement, or any other financial or regulatory filing. The content aligns with the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-07-28 Chinese
华邦健康第七届董事会第二十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 23rd meeting of the 7th Board of Directors of Huabang Life Health Co., Ltd. It details the meeting date, voting results, and the agenda items discussed, including amendments to company bylaws and election of board members. The document does not contain financial statements or detailed financial data but focuses on board decisions and governance matters. It is not a full annual or interim report, nor an earnings release or audit report. The content aligns with announcements related to changes or decisions in the company's board or senior management. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length is short and does not indicate it is a report publication announcement or regulatory filing. Confidence is high given the clear focus on board meeting resolutions and director elections.
2021-07-28 Chinese
独立董事提名人声明（刘忠海）
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors nominating an individual as an independent director candidate. It contains detailed declarations about the nominee's qualifications, compliance with various regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically about a nomination to the board. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and the content is substantive, not a mere announcement or certification.
2021-07-28 Chinese
华邦健康关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement from 华邦生命健康股份有限公司 regarding the election of a new board of directors. It details the nomination of candidates for the eighth board, their qualifications, and the process for approval at the upcoming shareholders' meeting. The content focuses on board member changes and related procedural information. There are no financial statements, earnings data, or audit information present. The document is not a report but an official announcement about board/management changes.
2021-07-28 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.